Patricia A Powers

Summary

Affiliation: Walter Reed Army Medical Center
Country: USA

Publications

  1. ncbi request reprint Tumor size and extent of disease at diagnosis predict the response to initial therapy for papillary thyroid carcinoma in children and adolescents
    Patricia A Powers
    Department of Pediatrics, Walter Reed Army Medical Center, Washington, DC 20307, USA
    J Pediatr Endocrinol Metab 16:693-702. 2003
  2. ncbi request reprint Treatment of recurrent papillary thyroid carcinoma in children and adolescents
    Patricia A Powers
    Department of Pediatrics, Walter Reed Army Medical Center, Washington, DC 20307 5001, USA
    J Pediatr Endocrinol Metab 16:1033-40. 2003
  3. ncbi request reprint The MACIS score predicts the clinical course of papillary thyroid carcinoma in children and adolescents
    Patricia A Powers
    Department of Pediatrics, Walter Reed Army Medical Center, Washington, DC 20307 5001, USA
    J Pediatr Endocrinol Metab 17:339-43. 2004
  4. ncbi request reprint Differentiated thyroid carcinoma that express sodium-iodide symporter have a lower risk of recurrence for children and adolescents
    Aneeta Patel
    Department of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814, USA
    Pediatr Res 52:737-44. 2002
  5. ncbi request reprint Intense expression of the b7-2 antigen presentation coactivator is an unfavorable prognostic indicator for differentiated thyroid carcinoma of children and adolescents
    Rima Shah
    Department of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814, USA
    J Clin Endocrinol Metab 87:4391-7. 2002

Collaborators

Detail Information

Publications5

  1. ncbi request reprint Tumor size and extent of disease at diagnosis predict the response to initial therapy for papillary thyroid carcinoma in children and adolescents
    Patricia A Powers
    Department of Pediatrics, Walter Reed Army Medical Center, Washington, DC 20307, USA
    J Pediatr Endocrinol Metab 16:693-702. 2003
    ..022) and dose (p = 0.002) required to achieve first remission. We conclude that extensive disease at diagnosis and larger tumor size predict failure to remit after initial treatment of PTC in children and adolescents...
  2. ncbi request reprint Treatment of recurrent papillary thyroid carcinoma in children and adolescents
    Patricia A Powers
    Department of Pediatrics, Walter Reed Army Medical Center, Washington, DC 20307 5001, USA
    J Pediatr Endocrinol Metab 16:1033-40. 2003
    ..There were no deaths. In conclusion, although we had only one child less than 10 years of age in our study, these and previous data suggest that treatment of recurrent PTC in children is generally effective...
  3. ncbi request reprint The MACIS score predicts the clinical course of papillary thyroid carcinoma in children and adolescents
    Patricia A Powers
    Department of Pediatrics, Walter Reed Army Medical Center, Washington, DC 20307 5001, USA
    J Pediatr Endocrinol Metab 17:339-43. 2004
    ..0005). A cutoff score of 4.0 provides a PPV of 29% and NPV of 94% in predicting recurrence, and a PPV of 43% and NPV of 91% in predicting persistent disease. MACIS scores may be useful in predicting outcome in the pediatric population...
  4. ncbi request reprint Differentiated thyroid carcinoma that express sodium-iodide symporter have a lower risk of recurrence for children and adolescents
    Aneeta Patel
    Department of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814, USA
    Pediatr Res 52:737-44. 2002
    ..06). We conclude that NIS expression is associated with a lower risk of recurrence for PTC and FTC of children and adolescents...
  5. ncbi request reprint Intense expression of the b7-2 antigen presentation coactivator is an unfavorable prognostic indicator for differentiated thyroid carcinoma of children and adolescents
    Rima Shah
    Department of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814, USA
    J Clin Endocrinol Metab 87:4391-7. 2002
    ..04). In conclusion, these data support the hypothesis that the antigen presentation coactivators B7-1 and B7-2 may be important for lymphocytic infiltration and the immune response against thyroid carcinoma...